Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 851 - 900 out of 10,983

Document Document Title
WO2005046599A3
alphabeta-Unsaturated sulfoxides of Formula I: (I) are useful as antiproliferative agents including, for example, anticancer agents, and as radioprotective and chemoprotective agents.  
WO/2005/092846A1
A method for reducing the cyanide levels in a mesotrione sample, said method comprising: (i) taking an aqueous solution of the mesotrione sample in an aqueous solvent, (ii) adjusting the pH of said aqueous solution to a value of 9.5 or h...  
WO/2005/092904A1
Novel styrylacrylonitrile compounds which are useful in treating a variety of cell proliferative disorders such as cancer are disclosed.  
WO/2005/092997A1
Disclosed is a surface treating agent containing a fluorine-containing polymer having: (A) a repeating unit derived from a fluorine-containing compound which is represented by the following formula: CH2=C(-X)-C(=O)-Y-[-(CH2)m-Z-]p-(CH2)n...  
WO/2005/090297A1
The invention relates to sulphonamide derivatives of formula (I), where RC is optionally substituted 4-6-membered heterocyclic ring containing one or more N atoms, or RC is -NR1R2, RA is a group having the formula (A), (B) or (C) RB is h...  
WO/2005/090296A2
The invention provides N-substituted benzenesulfonamides for use in treating or preventing cognitive disorders, such as Alzheimer's Disease. Compounds of particular interest are defined by Formula (I), wherein R1, R2, R3, R4, and R3, are...  
WO/2005/090298A1
The invention relates to sulphonamide derivatives of formula (I), where RC is optionally substituted 4-6-membered heterocyclic ring containing one or more N atoms, or RC forms together with the phenyl ring to which it is attached a benzo...  
WO/2005/089269A2
Substituted phenol derivatives of Formula (I) are useful as antiproliferative agents including, for example, anticancer agents, and as radioprotective and chemoprotective agents.  
WO/2005/089511A2
Crystalline salts, polymorphs, solvates, and hydrates of bicalutamide, 5-fluorouracil, donepezil, anastrozole, nelfinavir, mirtazapine, lansoprazole, and tamsulosin, or derivatives thereof are provided by the subject invention. Methods o...  
WO/2005/087710A1
A compound represented by the formula (1) (wherein the symbols are the same as defined in the description), a salt thereof, and a prodrug thereof. They unexpectedly have excellent GPR40 receptor agonistic activity and are excellent in pr...  
WO/2005/087700A2
The present invention discloses bisphenyl compounds of the formula (1): wherein R1, R2, R3, R4, R5, R6, X, Y, W are defined herein after. These compounds are useful as pharmaceuticals.  
WO/2005/085190A1
The invention relates to a method for processing ß-sulphatoethylsulphonylaniline-2-sulphonic acid which is present as a solution in an aqueous sulphuric acid. In a first step, the ß-sulphatoethylsulphonylaniline-2-sulphonic acid is pre...  
WO/2005/080309A1
There is provided a stereoselective route to a compound of formula (1): wherein R represents H or an alkali metal, Ar1 represents 4-chlorophenyl and Ar2 represents 2,5-difluorophenyl.  
WO2005063665B1
The invention provides para substituted dialkylphenol derivatives of propofol. The invention further provides pharmaceutical compositions comprising such analogs, methods for preparing such analogs, and methods of using such analogs to i...  
WO2005051899A3
A novel polymer electrolyte is provided that enables a solid polymer electrolyte used in fuel cells, for example, to have sufficient proton conductivity even in a low-water-content state or a zero-water-content state by using a monomer c...  
WO/2005/079700A2
The present invention relates to methods of using fluorosulfones for i) extinguishing fire by applying to the fire such a fluorosulfone, ii) preventing fire in an air-containing enclosed area containing combustible materials by introduci...  
WO/2005/079270A2
The present invention provides aryl nitrones, compositions comprising the same and methods of their use for the treatment or prevention of oxidative, ischemic, ischemia/reperfusion-related and chemokine mediated conditions.  
WO/2005/079863A1
It is intended to provide a contrast medium for thrombus formation capable of binding specifically to a thrombus, lowering background noise and thus improving the resolution in a contrast examination for thrombus formation; and a method ...  
WO/2005/078741A1
Disclosed are a mixture and a cation conductor which are capable of transferring cations without humidification even in the temperature range not higher than the boiling point of water. Also disclosed is an electrochemical device such as...  
WO/2005/077894A1
Polymorphs and solvates of racemic, enantiomerically pure, and enantiomerically mixed modafinil are formed and discussed. In addition, said forms are described as useful for the treatment of many conditions including, but not limited to,...  
WO/2005/077122A2
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of liver X receptors (LXRs).  
WO/2005/075426A1
The present invention relates to novel dipeptidyl peptidase IV (DPP-IV) inhibitors or general formula (1) useful for treating diabetes, non-insulin dependent diabetes mellitus, impaired glucose tolerance, inflammatory bowel disease, ulce...  
WO/2005/075417A1
The present invention relates to new fluorosulfone compounds. These fluorosulfone compounds have utility in preventing, controlling and extinguishing fire.  
WO2005056510A3
The present invention relates to novel compounds corresponding to the general formula (I) below: to compounds containing them, and to their use in pharmaceutical compositions intended for use in human or veterinary medicine, or alternati...  
WO/2005/073165A1
The invention aims at providing highly effective insecticides. Compounds represented by the general formula (1); insecticides containing the same as the active ingredient; and a process for the production thereof: (1) wherein A1, A2, A3 ...  
WO2005051898A3
The present invention relates to novel, non-secosteroidal, sulfonate and sulfonamide functional diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1alpha,25 dihydroxy vitamin D3. These com...  
WO2004014847A8
The present invention relates to sulfones that are useful in the treatment of chemokine-mediated disorders. In certain embodiments, the present invention concerns the compounds that are MCP-1 receptor antagonists.  
WO2005051888A3
The invention relates to compounds of the formula (I) in which: i and j=1; R1 is in position 3 or 4 on the phenyl ring and represents a cyano group, an alkoxy group substituted by halogen, a thioalkyl group, an alkylcarbonyl group or an ...  
WO2005037206A3
The present invention relates to a novel class of anti-cancer compounds which selectively target androgen receptor (AR)-expressing cancer, cells, such as prostate cancer cells and breast cancer cells, These agents comprise an androgen re...  
WO/2005/070883A1
The invention encompasses novel compounds of Formula I, which are nitric oxide-releasing prodrugs of diaryl-2-(5H)-furanones useful in the treatment of cyclooxygenase-2 mediated diseases. Formula (I). The invention also encompasses certa...  
WO/2005/070874A1
The invention encompasses novel compounds of Formula I, which are nitric oxide-releasing prodrugs of diaryl-2-(5H) furanones useful in the treatment of cyclooxygenase-2 mediated diseases. Formula (I). The invention also encompasses certa...  
WO/2005/068411A1
A process for the preparation of 6-fluoro-2-methyl-l-indanone which relates to a process of preferential cyclization of (3-fluorophenyl)-isopropenyl-ketone to obtain 6-fluoro-2-methyl­ 1-indanone regioisomer with respect to 4-fluoro-2-m...  
WO/2005/068415A1
Disclosed is a phenylalanine derivative having excellent VLA-4 inhibitory activity which is represented by the following general formula (1) or a salt thereof. (1) (In the formula, R1 represents an aromatic hydrocarbon group having 6-10 ...  
WO2005042478A3
The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.  
WO/2005/066119A2
Novel florfenicol compounds having the chemical structure: Or a pharmaceutically-acceptable salt thereof or a solvate thereof,or prodrug thereof, wherein R1 is CHCl2, CHClF, CHF2, CHBrCl, CH3, CH2N3, CH2CN, CH(R2)NH2 or CH X1X2; where R2...  
WO/2005/063665A1
The invention provides para substituted dialkylphenol derivatives of propofol. The invention further provides pharmaceutical compositions comprising such analogs, methods for preparing such analogs, and methods of using such analogs to i...  
WO/2005/063703A1
A novel process for producing a 2-halogenobenzamide compound useful as a raw material or active ingredient for medicines and agricultural chemicals. The process, which is for producing a 2-halogenobenzamide compound represented by the ge...  
WO/2005/063729A1
The present invention provides a novel compound represented by the formula (I) wherein each symbol is as defined in the specification, a salt thereof and a prodrug thereof having a superior GPR40 receptor function modulating action, whic...  
WO/2005/063018A1
Present invention relates to a haloalkene compound of the formula (I)or its salt: wherein each of X1 and X2 is halogen; Y is alkyl, haloalkyl or phenyl; n is 0 to 5; L is -C(=B)Q, -C(=B)B’Q, -C(=B)N(D)Q, -N(D)Q, -N(D)C(=B)Q, -N(D)C(=B)...  
WO2005023198A3
Co-crystals and solvates of racemic, enantiomerically pure, and enantiomerically mixed modafinil are formed and several important physical properties are modulated. The solubility, dissolution, bioavailability, dose response, and stabili...  
WO2004098516A3
The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, artherosclerosis and asthma.  
WO/2005/060692A2
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.  
WO/2005/058269A1
Described are merocyanine derivatives of formula (1a) or (1b) wherein n and o are integers from 2 to 4 and aminocyclohexenone intermediates. They are used in protecting human and animal hair and skin from UV radiation.  
WO/2005/056519A1
The present invention provides a compound represented by the formula (I): (INSERT CHEMICAL FORMULA) (wherein R1 is a lower alkyl substituted by a lower alkoxy or a heterocyclic group, or a heterocyclic group; R2 is a lower alkyl optional...  
WO/2005/057714A1
It is aimed to obtain a lithium secondary battery with excellent characteristics such as energy density and electromotive force, which is also excellent in cycle life and shelf life stability. Disclosed is an electrolyte solution for sec...  
WO/2005/056518A1
This invention discloses a series of sulfur- or oxygen-containing oxime ether compounds represented by the general formula (I), in which R, R,, X, n, Ar and F, are as defined in the specification, and their preparation methods. The compo...  
WO2004046094A9
The present invention provides histone deacetylase inhibitors of general formula (I), process for the preparation of such compounds and uses of the compounds in medicine.  
WO/2005/056510A2
The present invention relates to novel compounds corresponding to the general formula (I) below: to compounds containing them, and to their use in pharmaceutical compositions intended for use in human or veterinary medicine, or alternati...  
WO/2005/054181A1
It is intended to provide a medicinal composition containing, as the active ingredient, a compound specifically binding to KSRP or a functional fragment thereof and a method of screening this compound. A composition capable of regulating...  
WO/2005/054176A1
The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator act...  

Matches 851 - 900 out of 10,983